These enzymes can degrade extracellular matrix as well as promote cancer cell invasion, migration, and neovascularization [35], but, on the other hand, they are able to reduce cancer growth and vascularization by inducing the generation of angiogenesis inhibitors (angiostatin and tumstatin) [35,36,37,38]. The gene discussed is PLG; the disease is cancer.